CVS Hires Former Eli Lilly Executive -- WSJ
March 21 2018 - 3:02AM
Dow Jones News
By Sharon Terlep
This article is being republished as part of our daily
reproduction of WSJ.com articles that also appeared in the U.S.
print edition of The Wall Street Journal (March 21, 2018).
CVS Health Corp. tapped a former Eli Lilly & Co. finance
chief to run its pharmacy benefit business as the drugstore giant
works to complete an acquisition of insurer Aetna Inc.
Derica Rice, a longtime Eli Lilly chief financial officer, is
set to take over at CVS Caremark on March 30, according to an
internal CVS memo reviewed by The Wall Street Journal. Mr. Rice
will succeed Jonathan Roberts, who was promoted last year to the
role of chief operating officer at CVS Health.
"With growing concerns over the affordability of prescriptions,
the role of the pharmacy benefit manager has never been more
important to the health care system," CVS said in the memo,
announcing the appointment to managers.
Pharmacy benefit managers are health-care middlemen who help
select which drugs are covered for insured patients and negotiate
discounts with drugmakers.
CVS, with its $69 billion deal for Aetna, aims to create a
vertical health-care enterprise in which pharmacists are central to
patient care and the company's vast network of drugstores will
provide services from lab testing to the infusion of specialty
medications. The deal, which was announced in December, is awaiting
regulatory approval.
Mr. Rice worked at Lilly for about 27 years, serving as finance
chief from 2006 until retiring in December. He was interim CEO at
the Indianapolis drugmaker for a few months in 2013 when then-CEO
John Lechleiter took a medical leave.
Mr. Rice helped craft Lilly's strategy to weather a period of
patent expirations for top-selling drugs that caused the company's
sales to decline sharply in 2014. The company cut costs and
licensed rights to new drugs to help offset some of the sales
decline.
Write to Sharon Terlep at sharon.terlep@wsj.com
(END) Dow Jones Newswires
March 21, 2018 02:47 ET (06:47 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
CVS Health (NYSE:CVS)
Historical Stock Chart
From Sep 2023 to Sep 2024